Study Group: Oncology Reimbursement Experts (US)(?)
Council Members in this Study Group: 82
Request a survey with this Study Group
Leading Experts in this Study Group
 |
What is a GLG Leader? |
Taral Patel, MDOncologist
Mid Ohio Oncology Hematology Inc.
Taral Patel, MD, is an Oncologist in private practice with Mid Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been a principal investigator for multiple clinical trials in colon cancer, lung cancer, lymphoma, and growth factor. He has been on the...
Dea Belazi, PharmD, MPH, PAHMPharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM
Dea Belazi, PharmD, MPH, PAHM, is currently a consultant working with health plans and pharmaceutical companies. He was previously the Senior Director of Pharmacy Services for Independence Blue Cross, a large commercial and Medicare health plan in Pennsylvania. Prior to this position, he was the Associate...
Independent Contractor-Medical Director
SCHALLER ANDERSON, INC.
Arnold Greensher, MD, is a Medical Director for the commercial managed care section of Schaller Anderson Healthcare, Arizona. He is Board certified in Family Practice and Pediatrics and fellowship trained in Genetics. Dr. Greensher lectures widely on issues related to Medical Malpractice, Risk Management...
President
Prescriptive Choice Consulting Group
James McGinnis, PharmD, is the President of Prescriptive Choice Consulting Group, LLC, in Texas. Dr. McGinnis has more than 20 years of experience in all aspects of the managed pharmacy industry. He has developed a number of innovative pharmacy benefit designs and formulary based multi-tier benefit...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Oncologists (US) | 2254 |
| Economic Experts on Managed Care | 597 |
| Managed Care Experts | 526 |
| Hematologists and Oncologists in Private Practice (US) | 443 |
| Oncologists who Treat Hematologic Malignancies (US) | 883 |
| Hematologists (US) | 1022 |
| Oncologists in Private Practice in the U.S. | 432 |
GLG NewsSMAnalyses by this Study Group's Experts(?)
New data with low and high dose of Avastin with Taxoter
esults showed that PROVENGE patients experienced improved survival if they received more cells across the three doses of PROVENGE (higher cumulative TNC count (p=0.019)) or higher cumulative CD54 upregulation values (p=0.009). The effect on survival for TNCs appeared to reflect in part the patients'...
Outsourcing at all levels of the global economy is a reality of today's marketplace. Medical economics is a huge slice of that pie. U.S. and European standards have provided the highest basis for judging quality clinical research and development at great cost and careful effort. Thus no surprise that...
EOA has been well described and well known for over a half century. It is symptomatic in its inflammatory DIP/PIP erosive presentation and clinically has an end stage indistinguishable from common variety OA. Simple treatment with NSAIDs or hydroxychloroquin and contrast baths is uniformly...
Increased FDA warnings on ESAs, suchas Epogen, Procrit and Aranesp will provide payers the ability to further restrict these agents. Restrictions will come in the form of prior authorizations and other utilization management techniques.
Most Common Company Types:
- Office Based Private Practice or Clinic
- Consultancy, Healthcare-Focused
- Academic Medical Center/Hospital or Clinic
- Consultancy, Pharma-Focused
- Non-Academic Community Hospital or Clinic
- Blue Cross/Blue Shield Non-Profit Health Insurer
Most Common Job Types:
- Physician - Attending Physician
- President
- Principal
- Medical Director
- Partner
- Chief Executive Officer
- Physician - Director
- Chief Operating Officer
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms